A complex atherosclerotic phenotype of Mif gene-deficient mice in an atherogenic ApoE-/- background uncovers a novel connection between MIF and B cells

      Objectives: Macrophage migration inhibitory factor (MIF) is a chemokine-like inflammatory mediator that plays an important role in inflammatory diseases. MIF has been found to promote atherogenesis in several models. However, recent data suggest that MIF has a complex role in cardiovascular disease (CVD) including cardioprotective effects in models of myocardial ischemia/reperfusion injury. Here, we studied the impact of Mif gene deletion in the ApoE-/- background .
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect